Sign in
Stories
Neurodegenerative Disease Market Expansion
Share
ALS Treatment Withdrawal: FDA Concerns
Advancements in Cancer Treatment and Mar...
Advancements in Huntington's Disease Tre...
4DMT Presents Positive Interim Data
ACTICOR BIOTECH Delays Key Documents
ACTICOR BIOTECH: Financial Report Postpo...
Overview
API
Global neurodegenerative disease market projected to reach USD 96.4 billion by 2032, with a focus on emerging therapies for conditions like Alzheimer's and Parkinson's. Larimar Therapeutics reports positive top-line data for nomlabofusp, a treatment for Friedreich’s ataxia, with plans for accelerated approval submission.
Ask a question
How do advancements in treatments for neurodegenerative diseases align with broader efforts towards improving healthcare access and outcomes for affected individuals?
How might the increasing prevalence of neurological disorders impact healthcare systems and funding globally?
What are the potential implications of the projected growth in the neurodegenerative disease market on the pharmaceutical industry and medical research?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Feb 2024
Coverage